Phase IV Clinical Study of Safety and Tolerability of Oral Xeloda (Capecitabine) in Adjuvant Treatment of Resected Cancer of the Colon
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2015
At a glance
- Drugs Capecitabine (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 02 Jun 2006 New trial record.